Skip to main content
$3.20 $0.02 (0.6%)

04:00 PM EDT on 09/22/23

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

CAPS Rating: No stars

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections.

Current Price $3.20 Mkt Cap $266.9M
Open $3.20 P/E Ratio -2.51
Prev. Close $3.20 Div. (Yield) $0.00 (0.0%)
Daily Range $3.18 - $3.24 Volume 252,306
52-Wk Range $2.94 - $6.32 Avg. Daily Vol. 365,236

Caps

How do you think NASDAQ:AVIR will perform against the market?

Add Stock to CAPS Watchlist

All Players

3 Outperform
1 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AVIR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:AVIR Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:AVIR are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about AVIR.

No one has written a Pitch for AVIR stock yet. Tell us why you think AVIR will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in AVIR.

Score Leader

Under5b

Under5b (< 20) Score: +66.03

The Score Leader is the player with the highest score across all their picks in AVIR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Under5b < 20 7/17/2023 Underperform 5Y $3.61 -11.50% -4.17% +7.33 0 Comment
Magic100value 68.33 2/18/2022 Outperform 5Y $5.98 -46.57% -1.10% -45.47 0 Comment
geltam < 20 11/16/2021 Outperform 5Y $11.40 -71.97% -7.86% -64.11 0 Comment
darrellquock 43.83 6/30/2022 Outperform 5Y $7.18 -55.50% +14.40% -69.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AVIR.